Dr. Ruben Bonilla-Guerro

Dr. Ruben Bonilla-Guerrero – MD, FACMG, FAACC, MB(ASCP), CGMBS, director of pharmacogenomics and genetics at The Mayo Clinic for many years.  Nationally recognized leader in molecular diagnostics, ex-Quest Diagnostics director.  Dr Guerrero has developed the most comprehensive PGx assay in the world.  This proprietary assay identifies more genes than any other PGx test and holds a higher sensitivity level of testing.  This in conjunction with the most advanced PGx patient study report gives the provider more information in considering patient care.  The report is dynamically robust allowing the provider the ability to explore all related medications that might be medically indicated for the patient based on their unique metabolic needs.  The provider is also able to revisit their secure portal and pull up each patient’s report to consider future prescriptions.   Dr Guerrero also provides individual consultations with the provider as the report is reviewed free of charge as many times as may be necessary.